Prospective Registry of Patients With Acute Coronary Syndrome Treated With GENOSS Stent
Conditions: Acute Coronary Syndrome; Percutaneous Coronary Intervention Interventions: Device: Genoss DES Sponsors: Genoss Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials
The Effect of Modified Supine Position on Urinary Elimination After Percutaneous Coronary Intervention
Conditions: Urinary Retention Interventions: Other: Modified Supine Position Sponsors: Istanbul University - Cerrahpasa (IUC) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 6, 2023 Category: Research Source Type: clinical trials
Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease
Conditions: Chronic Limb-Threatening Ischemia Interventions: Device: MAGNITUDE Sirolimus-eluting Bioresorbable Scaffold; Device: Percutaneous Transluminal Angioplasty (PTA) Sponsors: R3 Vascular Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 6, 2023 Category: Research Source Type: clinical trials
The Percutaneous Coronary Intervention Registry in University Medical Center of Ho Chi Minh City
Conditions: Coronary Artery Disease Interventions: Procedure: Percutaneous Coronary Intervention Sponsors: University Medical Center Ho Chi Minh City (UMC) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 6, 2023 Category: Research Source Type: clinical trials
Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a study protocol for a randomized, double-blinded, three-arm parallel-group, controlled trial
DiscussionThe present study will be the first trial to evaluate the efficacy and safety of early treatment with the combination of standard-dose empagliflozin and colchicine as well as high-dose empagliflozin in non-diabetic patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction. The results of this research will represent a significant step forward in the treatment of patients with acute myocardial infarction.Trial registrationClinical trial ID: IRCT20111206008307N39. Registration date: 27 October 2022.Graphical Abstract (Source: Trials)
Source: Trials - October 6, 2023 Category: Research Source Type: clinical trials
The SIR-POBA Shunt Trial
Condition: Arteriovenous Fistula Stenosis Intervention: Radiation: Balloon Angioplasty Sponsors: Paracelsus Medical University; MedAlliance Swiss Medical Technology Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials
The SIR-POBA Bypass Trial
Conditions: Peripheral Arterial Occlusive Disease; Bypass Complication; Femoropopliteal Artery Occlusion; Femoropopliteal Stenosis; Critical Limb-Threatening Ischemia; Claudication, Intermittent Intervention: Procedure: Balloon Angioplasty Sponsors: Paracelsus Medical University; MedAlliance Swiss Medical Technology Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials
The SIR-POBA Shunt Trial
Conditions: Arteriovenous Fistula Stenosis Interventions: Radiation: Balloon Angioplasty Sponsors: Paracelsus Medical University; MedAlliance Swiss Medical Technology Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials
The SIR-POBA Bypass Trial
Conditions: Peripheral Arterial Occlusive Disease; Bypass Complication; Femoropopliteal Artery Occlusion; Femoropopliteal Stenosis; Critical Limb-Threatening Ischemia; Claudication, Intermittent Interventions: Procedure: Balloon Angioplasty Sponsors: Paracelsus Medical University; MedAlliance Swiss Medical Technology Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials
Rapamycin Coated Balloon Dilation Catheter for Arteriovenous Fistula
Condition: Peripheral Arterial Disease Interventions: Procedure: Rapamycin drug balloon angioplasty; Procedure: Paclitaxel drug balloon angioplasty Sponsor: Shanghai Bomaian Medical Technology Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
